You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 15, Issue 21

November-1 2023 - 193 articles

Cover Story: Many cancer survivors report symptoms long after completing their cancer treatment. This can impact their quality of life and ability to return to daily activities, including the ability to work. We explored symptoms and their severity reported by 561 cancer survivors after primary cancer treatment with curative intent who were attending the Sydney Cancer Survivorship Centre clinic in Sydney, Australia, for the first time. We were interested in how symptoms clustered together and the impact of symptoms and symptom clusters on the ability to work. We found that survivors who reported higher rates of pain, emotional and cognitive clusters of symptoms were more likely to be limited in their ability to work. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (193)

  • Review
  • Open Access
9 Citations
3,328 Views
18 Pages

6 November 2023

Nonalcoholic fatty liver disease (NAFLD) is emerging as an important risk factor for hepatocellular carcinoma (HCC), whose prevalence is rising. Although the mechanisms of progression from NAFLD to HCC are not fully elucidated, tumor necrosis factor-...

  • Article
  • Open Access
11 Citations
2,106 Views
20 Pages

6 November 2023

Bladder cancer (BLCA) is one of the cancers that is highly sensitive to specific non-invasive tumor biomarkers that facilitate early diagnosis. Exosome-derived long non-coding RNAs (lncRNAs) hold promise as diagnostic biomarkers for BLCA. In this stu...

  • Article
  • Open Access
2 Citations
2,854 Views
12 Pages

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer

  • Chin-Chia Wu,
  • Chuan-Yin Fang,
  • Ben-Hui Yu,
  • Chun-Ming Chang,
  • Ta-Wen Hsu,
  • Chung-Lin Hung,
  • Shih-Kai Hung,
  • Wen-Yen Chiou and
  • Jui-Hsiu Tsai

6 November 2023

The dose–response effect of proton pump inhibitors on colorectal cancer prognosis is still under exploration. This population-based study in Taiwan was designed to examine the effect of proton pump inhibitors on overall death, colorectal cancer...

  • Article
  • Open Access
3 Citations
2,285 Views
15 Pages

An Interpretable Radiomics Model Based on Two-Dimensional Shear Wave Elastography for Predicting Symptomatic Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma

  • Xian Zhong,
  • Zohaib Salahuddin,
  • Yi Chen,
  • Henry C. Woodruff,
  • Haiyi Long,
  • Jianyun Peng,
  • Xiaoyan Xie,
  • Manxia Lin and
  • Philippe Lambin

6 November 2023

Objective: The aim of this study was to develop and validate an interpretable radiomics model based on two-dimensional shear wave elastography (2D-SWE) for symptomatic post-hepatectomy liver failure (PHLF) prediction in patients undergoing liver rese...

  • Article
  • Open Access
2,693 Views
9 Pages

Axillary Reverse Mapping in Clinically Node-Positive Breast Cancer Patients

  • Masakuni Noguchi,
  • Masafumi Inokuchi,
  • Miki Yokoi-Noguchi,
  • Emi Morioka,
  • Yusuke Haba,
  • Tomoko Takahashi,
  • Akihiro Shioya and
  • Sohsuke Yamada

6 November 2023

Background: Axillary reverse mapping (ARM) nodes are involved in a significant proportion of clinically node-positive (cN+) breast cancer patients. However, neoadjuvant chemotherapy (NAC) is effective at decreasing the incidence of nodal metastases i...

  • Review
  • Open Access
8 Citations
3,001 Views
19 Pages

Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy

  • Dana Antonia Tapoi,
  • Maria-Linda Popa,
  • Cristiana Tanase,
  • Diana Derewicz and
  • Ancuța-Augustina Gheorghișan-Gălățeanu

6 November 2023

Adenohypophysal pituitary tumors account for 10–15% of all intracranial tumors, and 25–55% display signs of invasiveness. Nevertheless, oncology still relies on histopathological examination to establish the diagnosis. Considering that th...

  • Review
  • Open Access
24 Citations
3,942 Views
41 Pages

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges

  • Wojciech Szymanowski,
  • Anna Szymanowska,
  • Anna Bielawska,
  • Gabriel Lopez-Berestein,
  • Cristian Rodriguez-Aguayo and
  • Paola Amero

6 November 2023

Ovarian cancer (OC) is the most common lethal gynecologic cause of death in women worldwide, with a high mortality rate and increasing incidence. Despite advancements in the treatment, most OC patients still die from their disease due to late-stage d...

  • Article
  • Open Access
7 Citations
2,111 Views
13 Pages

Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era

  • Yoshiko Nakamura,
  • Masashi Hirooka,
  • Atsushi Hiraoka,
  • Yohei Koizumi,
  • Ryo Yano,
  • Makoto Morita,
  • Yuki Okazaki,
  • Yusuke Imai,
  • Hideko Ohama and
  • Kana Hirooka
  • + 6 authors

6 November 2023

Treatment modalities for advanced hepatocellular carcinoma (HCC) have changed dramatically, with systemic therapy as the primary option. However, the effect of sequential treatment on prognosis remains unclear. This retrospective study included patie...

  • Review
  • Open Access
2 Citations
2,984 Views
26 Pages

Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview

  • Wellington Francisco Rodrigues,
  • Camila Botelho Miguel,
  • Melissa Carvalho Martins de Abreu,
  • Jamil Miguel Neto and
  • Carlo José Freire Oliveira

6 November 2023

Hodgkin’s lymphoma (HL) is a lymphatic neoplasm typically found in the cervical lymph nodes. The disease is multifactorial, and in recent years, the relationships between various vascular molecules have been explored in the field of vascular bi...

  • Review
  • Open Access
39 Citations
8,836 Views
18 Pages

PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities

  • Wojciech Wiese,
  • Julia Barczuk,
  • Olga Racinska,
  • Natalia Siwecka,
  • Wioletta Rozpedek-Kaminska,
  • Artur Slupianek,
  • Radoslaw Sierpinski and
  • Ireneusz Majsterek

5 November 2023

Blood malignancies remain a therapeutic challenge despite the development of numerous treatment strategies. The phosphatidylinositol-3 kinase (PI3K)/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway plays a central role...

of 20

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694Creative Common CC BY license